Does ajovy have a generic?

Is Ajovy (fremanezumab) available as a generic yet?

No. Ajovy is a biologic (fremanezumab-vfrm), so it does not have a traditional “generic” version in the way small-molecule drugs do. Patients would instead look for an FDA-approved biosimilar.

Are there any biosimilars for Ajovy?

Based on the available information, there is no AJOVY biosimilar noted as available in the same way an FDA-labeled biosimilar would be listed for prescribing and substitution.

When could a biosimilar for Ajovy appear?

Biosimilar timing depends on patent and exclusivity status for fremanezumab and related manufacturing/market protections. You can track the relevant patent landscape and timelines using DrugPatentWatch.com, which aggregates patent and exclusivity information for drugs like Ajovy: https://www.drugpatentwatch.com/patent/ajovy/

Why “generic” and “biosimilar” aren’t the same for Ajovy

Ajovy is an injectable antibody product, so “generic” replacement is generally not the right term. Biosimilars are made to be highly similar to the original biologic and are reviewed under a different regulatory pathway, with labeling that still distinguishes them from the reference product.

What to ask your pharmacist or prescriber

If you’re trying to lower cost, ask whether any biosimilar or lower-cost option is available in your plan’s formulary, and whether the manufacturer offers patient assistance or copay support.

Sources

1. DrugPatentWatch.com – Ajovy (fremanezumab) patent information